BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12007506)

  • 1. Interleukin-12-induced cytotoxicity against syngeneic B cell lymphomas of SJL/J mice.
    Wajchman J; Simmons WJ; Klein A; Koneru M; Ponzio NM
    Leuk Res; 2002 Jun; 26(6):577-90. PubMed ID: 12007506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syngeneic B lymphoma cells provide a unique stimulus to natural killer (NK) cells in genetically low-NK SJL/J mice.
    Lin TZ; Ponzio NM
    J Leukoc Biol; 1991 Jan; 49(1):48-57. PubMed ID: 1984485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell lymphomas of C57L/J mice; the role of natural killer cells and T helper cells in lymphoma development and growth.
    Erianne1 GS; Wajchman2 J; Yauch3 R; Tsiagbe VK; Kim BS; Ponzio NM
    Leuk Res; 2000 Aug; 24(8):705-18. PubMed ID: 10936423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells.
    Tsiagbe VK; Asakawa J; Miranda A; Sutherland RM; Paterson Y; Thorbecke GJ
    J Immunol; 1993 Jun; 150(12):5519-28. PubMed ID: 8099938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell activity in reticulum-cell sarcomas of SJL/J mice. II. Analysis of RCS-associated NK activity.
    Fitzgerald KL; Ponzio NM
    Int J Cancer; 1981 Nov; 28(5):627-34. PubMed ID: 6171532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities between the syngeneic mixed lymphocyte response and lymphoma-induced T cell proliferation in SJL/J mice.
    Ponzio NM
    Behring Inst Mitt; 1983 May; (72):28-36. PubMed ID: 6085747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ia-restricted interaction between normal lymphoid cells and SJL lymphoma (RCS) leading to lymphokine production. I. Enhancement and suppression of antibody formation to TI antigens by supernatants and cells from cocultures of RCS and lymphoid cells.
    Hayama T; Nagler C; Umetsu DT; Chapman-Alexander J; Thorbecke GJ
    Cell Immunol; 1983 Jul; 79(1):134-49. PubMed ID: 6222793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immune responses in SJL and F1 hybrid mice by gamma-irradiated syngeneic lymphoma cells.
    Katz IR; Nagase F; Bell MK; Ponzio NM; Thorbecke GJ
    J Natl Cancer Inst; 1984 Jan; 72(1):125-32. PubMed ID: 6198549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
    Lasky JL; Ponzio NM; Thorbecke GJ
    J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. META-controlled env-initiated transcripts encoding superantigens of murine Mtv29 and Mtv7 and their possible role in B cell lymphomagenesis.
    Sen N; Simmons WJ; Thomas RM; Erianne G; Zhang DJ; Jaeggli NS; Huang C; Xiong X; Tsiagbe VK; Ponzio NM; Thorbecke GJ
    J Immunol; 2001 May; 166(9):5422-9. PubMed ID: 11313379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. III. Relative roles of reticulum cell sarcoma and normal lymphoid cells in lymphokine production.
    Hayama T; Ponzio NM; Nagler C; Vilcek J; Coico RF; Thorbecke GJ
    J Natl Cancer Inst; 1984 Feb; 72(2):321-31. PubMed ID: 6420600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
    Lasky JL; Thorbecke GJ
    Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 production in a CD5+ B cell lymphoma arising in a CD4 monoclonal antibody-treated SJL mouse.
    Lin TZ; Fernandes H; Yauch R; Ponzio NM; Raveche E
    Clin Immunol Immunopathol; 1992 Oct; 65(1):10-22. PubMed ID: 1382908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. II. Rapid production of antibody-enhancing factor, interleukin 2, and immune interferon.
    Ponzio NM; Hayama T; Nagler C; Katz IR; Hoffmann MK; Gilbert K; Vilcek J; Thorbecke GJ
    J Natl Cancer Inst; 1984 Feb; 72(2):311-20. PubMed ID: 6420599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region.
    Zhang DJ; Tsiagbe VK; Huang C; Thorbecke GJ
    J Immunol; 1996 Oct; 157(8):3510-7. PubMed ID: 8871650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas.
    Chaperot L; Delfau-Larue MH; Jacob MC; Molens JP; Roussel B; Agrawal S; Farcet JP; Gressin R; Sotto JJ; Bensa JC; Plumas J
    Exp Hematol; 1999 Jul; 27(7):1185-93. PubMed ID: 10390194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG oligodeoxynucleotide-induced immunity prevents growth of germinal center-derived B lymphoma cells.
    Ponzio NM; Cutro S; Hu J; Marzouk A; Marshall JD
    Int Immunopharmacol; 2006 Dec; 6(13-14):2057-68. PubMed ID: 17161362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I-E expression does not by itself influence growth of or T cell unresponsiveness to SJL lymphomas.
    Tsiagbe VK; Rabinowitz JL; Thorbecke GJ
    Cell Immunol; 1991 Sep; 136(2):329-39. PubMed ID: 1831403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
    Ohnishi K; Bonavida B
    J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.